Viewing nowGlymeperide Tablet 4mg (Glymeperide)
Glimepiride 4mg
Tablet · Prescription medication
Boryeong Biopharma Co., Ltd.

MFDS item code 201904175 · Approved 2019.06.14 · Insurance code 670501700
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be used alone, but if blood sugar control is insufficient, it can be combined with oral hypoglycemic agents or insulin. Especially when sulfonylureas or metformin monotherapy are ineffective, it can be taken with metformin to achieve more effective blood sugar control. Thus, it helps manage blood sugar levels through either monotherapy or combination therapy, depending on the individual patient's condition. Consequently, this medication improves blood sugar control in patients with type 2 diabetes.
Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering medicine to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering medicines. When switching from another oral glucose-lowering medicine to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Patients allergic to this medication or to sulfonylureas or sulfonamides should also avoid it. There is no experience using this medication in patients with severe liver or kidney dysfunction, so transitioning to insulin therapy is recommended. Women who are pregnant or may become pregnant, and nursing mothers should not take this medication. Insulin therapy is more appropriate for patients with severe infections, pre- or post-surgery, or those with severe trauma. Gastric disturbances such as diarrhea or vomiting can impede food absorption and increase the risk of hypoglycemia. This medication contains lactose and should not be administered to patients with genetic issues such as lactose intolerance or lactase deficiency. In the first week of treatment, there is a high risk of hypoglycemia, so monitoring should be particularly attentive. Elderly individuals, those with malnutrition, irregular meals, skipped meals, excessive exercise, imbalanced carbohydrate intake, or alcohol consumers are at higher risk of hypoglycemia. Patients with kidney or liver dysfunction may also be more sensitive to hypoglycemia, necessitating caution. Extra attention should be paid in cases of other endocrine disorders, overdosing on medications, or taking multiple drugs simultaneously. In such cases, blood sugar levels should be checked frequently, and if hypoglycemic symptoms occur, the physician or pharmacist should be notified immediately. This medication may cause hypoglycemia, and symptoms may include headaches, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and decreased consciousness. Severe hypoglycemia may exhibit symptoms similar to a stroke, necessitating immediate treatment. Temporary blurred vision may occur, as well as gastrointestinal disturbances leading to nausea, vomiting, abdominal pain, and diarrhea. Liver dysfunction or blood abnormalities and allergic reactions may occur rarely, so immediate consultation with medical personnel is advised for any unusual symptoms. When taking this medication, regular meals and exercise, along with weight management, are crucial. If hypoglycemia occurs, sugar or sweet drinks should be consumed quickly to raise blood sugar levels, and it is advisable to always carry some sugar. Regular blood sugar and urine tests should be conducted during treatment to monitor the medication's effectiveness. Caution is advised when driving or operating machinery, as hypoglycemia or hyperglycemia may impair concentration. When taking this medication with other drugs, it may affect blood sugar control, so patients must inform their doctor or pharmacist about any medications they are taking. Especially, using drugs that affect the enzymes that break down this medication in the liver may alter its effectiveness. Alcohol consumption can unpredictably alter the blood sugar-lowering effects of this medication. Women who are pregnant or breastfeeding should avoid this medication, as it may affect the fetus or newborn; transitioning to insulin therapy is safer. The safety and efficacy of this medication in children under 18 have not been established, so its use is not recommended. Elderly patients may have reduced kidney function and may require dose adjustments. In cases of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment, and patients must be closely monitored for at least 24-48 hours. This medication should be kept out of reach of children, and it is important to store it sealed in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to avoid direct sunlight and to store it at room temperature between 1 to 30 degrees Celsius.
Light blue rectangular tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Boryeong Biopharma Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.